{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:13:11Z","timestamp":1794003191646,"version":"4.8.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jhepr.2021.100249","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T07:56:40Z","timestamp":1611734200000},"page":"100249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?"],"prefix":"10.1016","volume":"3","author":[{"given":"Anna","family":"Sessa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Allaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Lebray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mourad","family":"Medmoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Tiritilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Iaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.jhepr.2021.100249_bib1","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver","volume":"34","author":"M\u00f8ller","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100249_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2010.02.023","article-title":"Cirrhotic cardiomyopathy","volume":"53","author":"M\u00f8ller","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100249_bib3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100249_bib4","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/hep.30824","article-title":"Liver injury and failure in critical illness","volume":"70","author":"Horvatits","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/hrt.13.3.273","article-title":"The liver IN heart failure relation OF anatomical, functional, and circulatory changes","volume":"13","author":"Sherlock","year":"1951","journal-title":"Br Heart J"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","article-title":"Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: assessment of Reduction in Mortality and Morbidity (CHARM) program","volume":"11","author":"Allen","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/jhep.2003.50062","article-title":"Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations","volume":"37","author":"Myers","year":"2003","journal-title":"Hepatol Baltim Md"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100249_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients","volume":"16","author":"van Deursen","year":"2010","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jhepr.2021.100249_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(61)90093-6","article-title":"Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes","volume":"30","author":"Richman","year":"1961","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100249_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCHEARTFAILURE.109.872556","article-title":"Clinical predictors of hepatic fibrosis in chronic advanced heart failure","volume":"3","author":"Gelow","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100249_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/heartasia-2011-010023","article-title":"Liver diseases in heart failure","volume":"3","author":"Maleki","year":"2011","journal-title":"Heart Asia"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100249_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2010.09.010","article-title":"Cardiovascular diseases and the liver","volume":"15","author":"Weisberg","year":"2011","journal-title":"Clin Liver Dis"},{"issue":"7","key":"10.1016\/j.jhepr.2021.100249_bib13","first-page":"932","article-title":"The liver in heart failure: a biopsy and explant series of the histopathologic and laboratory findings with a particular focus on pre-cardiac transplant evaluation","volume":"28","author":"Louie","year":"2015","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.27387","article-title":"Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces","volume":"61","author":"Simonetto","year":"2015","journal-title":"Hepatol Baltim Md"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0168-8278(86)80043-5","article-title":"Morphologic features of hepatic injury in cardiac disease and shock","volume":"2","author":"Lefkowitch","year":"1986","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2021.100249_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/hrt.2006.094516","article-title":"Hepatic changes in the failing Fontan circulation","volume":"93","author":"Kiesewetter","year":"2007","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/thx.26.3.240","article-title":"Surgical repair of tricuspid atresia","volume":"26","author":"Fontan","year":"1971","journal-title":"Thorax"},{"key":"10.1016\/j.jhepr.2021.100249_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2016.05.035","article-title":"The fontan epidemic: population projections from the Australia and New Zealand fontan registry","volume":"219","author":"Schilling","year":"2016","journal-title":"Int J Cardiol"},{"issue":"11 Suppl 1","key":"10.1016\/j.jhepr.2021.100249_bib19","first-page":"S32","article-title":"Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand","volume":"130","author":"d\u2019Udekem","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100249_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.107.738559","article-title":"Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery","volume":"117","author":"Khairy","year":"2008","journal-title":"Circ"},{"key":"10.1016\/j.jhepr.2021.100249_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000696","article-title":"Evaluation and management of the child and adult with fontan circulation: a scientific statement from the American heart association","author":"Rychik","year":"2019","journal-title":"Circ"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4037\/NCI.0b013e31829744c7","article-title":"Long-term issues after the Fontan procedure","volume":"24","author":"McRae","year":"2013","journal-title":"AACN Adv Crit Care"},{"issue":"9","key":"10.1016\/j.jhepr.2021.100249_bib23","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1007\/s00380-015-0743-4","article-title":"Risk factors and serological markers of liver cirrhosis after Fontan procedure","volume":"31","author":"Shimizu","year":"2016","journal-title":"Heart Vessels"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/ejcts\/ezu015","article-title":"The extracardiac conduit Fontan procedure in Australia and New Zealand: hypoplastic left heart syndrome predicts worse early and late outcomes","volume":"46","author":"Iyengar","year":"2014","journal-title":"Eur J Cardio-thorac Surg Off J Eur Assoc Cardio-thorac Surg"},{"issue":"7","key":"10.1016\/j.jhepr.2021.100249_bib25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00246-012-0315-7","article-title":"The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium","volume":"33","author":"Rychik","year":"2012","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100249_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.athoracsur.2008.03.077","article-title":"Liver and cardiac function in the long term after Fontan operation","volume":"86","author":"Camposilvan","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"21","key":"10.1016\/j.jhepr.2021.100249_bib27","first-page":"1750","article-title":"Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors","volume":"96","author":"Baek","year":"2010","journal-title":"Heart Br Card Soc"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.healun.2013.10.033","article-title":"Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function","volume":"33","author":"Simpson","year":"2014","journal-title":"J\u00a0Heart Lung Transpl Off Publ Int Soc Heart Transpl"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib29","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.25692","article-title":"Congenital heart disease and the liver","volume":"56","author":"Asrani","year":"2012","journal-title":"Hepatol Baltim Md"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100249_bib30","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jtcvs.2004.10.005","article-title":"Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma","volume":"129","author":"Ghaferi","year":"2005","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jhepr.2021.100249_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2013.06.008","article-title":"Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study","author":"Elder","year":"2013","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.jhepr.2021.100249_bib32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2015.09.017","article-title":"Intersections between microbiome and heart failure: revisiting the gut hypothesis","volume":"21","author":"Nagatomo","year":"2015","journal-title":"J\u00a0Card Fail"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","article-title":"The role of the gut microbiome in chronic liver disease: the clinical evidence revised","volume":"1","author":"Schwenger","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2021.100249_bib34","article-title":"Epigenetic-sensitive challenges of cardiohepatic interactions: clinical and therapeutic implications in heart failure patients","author":"Benincasa","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100249_bib35","first-page":"697","article-title":"Cardiac hepatopathy before and after heart transplantation","volume":"18","author":"Dichtl","year":"2005","journal-title":"Transpl Int Off J Eur Soc Organ Transpl"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib36","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijcard.2012.05.003","article-title":"Congestive hepatopathy and hypoxic hepatitis in heart failure: a cardiologist\u2019s point of view","volume":"166","author":"Kavoliuniene","year":"2013","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.jhepr.2021.100249_bib37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3109\/00365529609010358","article-title":"Serum\/ascites albumin gradient: its value as a rational approach to the differential diagnosis of ascites","volume":"31","author":"Akriviadis","year":"1996","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100249_bib38","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1089-3261(02)00056-9","article-title":"The liver in heart failure","volume":"6","author":"Giallourakis","year":"2002","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100249_bib39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00004836-198808000-00013","article-title":"Cardiac ascites: a characterization","volume":"10","author":"Runyon","year":"1988","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100249_bib40","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/MCG.0b013e318198113b","article-title":"Usefulness of serum N-terminal-ProBNP in distinguishing ascites due to cirrhosis from ascites due to heart failure","volume":"44","author":"Sheer","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib41","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/hep.26643","article-title":"Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: a diagnostic accuracy study","volume":"59","author":"Farias","year":"2014","journal-title":"Hepatol Baltim Md"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00000441-197303000-00001","article-title":"The liver in congestive heart failure: a review","volume":"265","author":"Dunn","year":"1973","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib43","first-page":"135","article-title":"Liver abnormalities in cardiac diseases and heart failure","volume":"20","author":"Alvarez","year":"2011","journal-title":"Int J Angiol Off Publ Int Coll Angiol Inc"},{"issue":"7","key":"10.1016\/j.jhepr.2021.100249_bib44","first-page":"491","article-title":"MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery","volume":"99","author":"Assenza","year":"2013","journal-title":"Heart Br Card Soc"},{"issue":"10","key":"10.1016\/j.jhepr.2021.100249_bib45","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.amjcard.2017.02.005","article-title":"Mortality risk stratification in fontan patients who underwent heart transplantation","volume":"119","author":"Berg","year":"2017","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.healun.2015.10.008","article-title":"Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: evidence from the registry of the United Network for Organ Sharing","volume":"35","author":"Deo","year":"2016","journal-title":"J\u00a0Heart Lung Transpl Off Publ Int Soc Heart Transpl"},{"issue":"7","key":"10.1016\/j.jhepr.2021.100249_bib47","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.healun.2014.12.009","article-title":"Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction","volume":"34","author":"Farr","year":"2015","journal-title":"J\u00a0Heart Lung Transpl Off Publ Int Soc Heart Transpl"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.athoracsur.2015.06.063","article-title":"Modified model for end-stage liver disease excluding INR (MELD-XI) score predicts early death after pediatric heart transplantation","volume":"101","author":"Grimm","year":"2016","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100249_bib49","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.healun.2012.02.027","article-title":"Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system","volume":"31","author":"Yang","year":"2012","journal-title":"J\u00a0Heart Lung Transpl Off Publ Int Soc Heart Transpl"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100249_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2017-000598","article-title":"Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure","volume":"4","author":"Sato","year":"2017","journal-title":"Open Heart"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib51","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ehf2.12222","article-title":"Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction","volume":"5","author":"Yoshihisa","year":"2018","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib52","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1148\/radiol.2018170601","article-title":"Quantitative elastography methods in liver disease: current evidence and future directions","volume":"286","author":"Kennedy","year":"2018","journal-title":"Radiology"},{"issue":"18","key":"10.1016\/j.jhepr.2021.100249_bib53","first-page":"1499","article-title":"Liver stiffness measurements for evaluation of central venous pressure in congenital heart diseases","volume":"101","author":"Jalal","year":"2015","journal-title":"Heart Br Card Soc"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100249_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/hep.22594","article-title":"Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency","volume":"48","author":"Lebray","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhepr.2021.100249_bib55","first-page":"1187","article-title":"Value of virtual touch quantification elastography for assessing liver congestion in patients with heart failure","volume":"80","author":"Yoshitani","year":"2016","journal-title":"Circ J Off J Jpn Circ Soc"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib56","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jhep.2009.11.018","article-title":"Liver stiffness is directly influenced by central venous pressure","volume":"52","author":"Millonig","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100249_bib57","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/hep.30048","article-title":"Assessment of advanced liver fibrosis and the risk for hepatic decompensation in patients with congestive hepatopathy","volume":"68","author":"Lemmer","year":"2018","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100249_bib58","first-page":"1024","article-title":"Imaging findings of congestive hepatopathy","volume":"36","author":"Wells","year":"2016","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"issue":"9","key":"10.1016\/j.jhepr.2021.100249_bib59","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2012.146","article-title":"Liver: transjugular liver biopsy yields high-quality samples","volume":"9","author":"Cholongitas","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jhepr.2021.100249_bib60","first-page":"1552","article-title":"Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity","volume":"27","author":"Dai","year":"2014","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib61","doi-asserted-by":"crossref","first-page":"182","DOI":"10.14740\/gr875e","article-title":"Histology and glutamine synthetase immunoreactivity in liver biopsies from patients with congestive heart failure","volume":"10","author":"Horvath","year":"2017","journal-title":"Gastroenterol Res"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100249_bib62","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/PAS.0000000000001250","article-title":"Validation of a congestive hepatic fibrosis scoring system","volume":"43","author":"Bosch","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.jhepr.2021.100249_bib63","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1097\/PAS.0000000000001163","article-title":"Heterogeneity of fibrosis in liver biopsies of patients with heart failure undergoing heart transplant evaluation","volume":"42","author":"Dhall","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100249_bib64","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/icvts\/ivu438","article-title":"Mortality after cardiac surgery in patients with liver cirrhosis classified by the Child-Pugh score","volume":"20","author":"Jacob","year":"2015","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib65","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0168-8278(87)80542-1","article-title":"Effects of captopril on renal function in patients with cirrhosis and ascites","volume":"4","author":"Daskalopoulos","year":"1987","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100249_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/009127000004000102","article-title":"Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure","volume":"40","author":"Sokol","year":"2000","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100249_bib67","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/j.1552-4604.1998.tb04434.x","article-title":"Pharmacokinetics and pharmacodynamics of irbesartan in patients with hepatic cirrhosis","volume":"38","author":"Marino","year":"1998","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib68","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0009-9236(97)90029-1","article-title":"Pharmacokinetics of valsartan in patients with liver disease","volume":"62","author":"Brookman","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100249_bib69","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00003495-199754060-00007","article-title":"A\u00a0review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension","volume":"54","author":"Gillis","year":"1997","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/bdd.2510060204","article-title":"Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study","volume":"6","author":"Zaman","year":"1985","journal-title":"Biopharm Drug Dispos"},{"issue":"11","key":"10.1016\/j.jhepr.2021.100249_bib71","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/j.1552-4604.1987.tb05583.x","article-title":"Pharmacokinetics of esmolol in hepatic disease","volume":"27","author":"Buchi","year":"1987","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100249_bib72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/j.1552-4604.1983.tb02721.x","article-title":"Clinical experience with atenolol in patients with chronic liver disease","volume":"23","author":"Kirch","year":"1983","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/clpt.1991.23","article-title":"Furosemide absorption in patients with cirrhosis","volume":"49","author":"Fredrick","year":"1991","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jhepr.2021.100249_bib74","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.1840090504","article-title":"Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients","volume":"9","author":"Lewis","year":"1989","journal-title":"Hepatol Baltim Md"},{"issue":"23","key":"10.1016\/j.jhepr.2021.100249_bib75","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1161\/CIRCULATIONAHA.108.814863","article-title":"Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device","volume":"120","author":"Russell","year":"2009","journal-title":"Circ"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100249_bib76","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.healun.2012.02.008","article-title":"Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction","volume":"31","author":"Chokshi","year":"2012","journal-title":"J\u00a0Heart Lung Transpl Off Publ Int Soc Heart Transpl"},{"issue":"5","key":"10.1016\/j.jhepr.2021.100249_bib77","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.clinre.2018.03.006","article-title":"Predictive value of liver damage for severe early complications and survival after heart transplantation: a retrospective analysis","volume":"42","author":"Lebray","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/TP.0b013e3181ac60db","article-title":"Combined heart and liver transplantation: a single-center experience","volume":"88","author":"Raichlin","year":"2009","journal-title":"Transplant"},{"key":"10.1016\/j.jhepr.2021.100249_bib79","article-title":"Cardiac Hepatopathy","author":"Fortea","year":"2019","journal-title":"Liver Pathol"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib80","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000001978","article-title":"Contemporary outcomes of combined heart-liver transplant in patients with congenital heart disease","volume":"102","author":"Bryant","year":"2018","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clinre.2018.08.009","article-title":"Combined heart and liver transplantation: state of knowledge and outlooks","volume":"43","author":"Lebray","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhepr.2021.100249_bib82","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.13500","article-title":"Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease","author":"Sagawa","year":"2020","journal-title":"Hepatol Res Off J Jpn Soc Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib83","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/hep.30194","article-title":"Hepatocellular carcinoma as a complication of vascular disease of the liver after fontan procedure","volume":"69","author":"Mazzarelli","year":"2019","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100249_bib84","first-page":"1155","article-title":"Liver cirrhosis and\/or hepatocellular carcinoma occurring late after the fontan procedure - a nationwide survey in Japan","volume":"82","author":"Kuwabara","year":"2018","journal-title":"Circ J Off J Jpn Circ Soc"},{"key":"10.1016\/j.jhepr.2021.100249_bib85","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijcard.2020.08.057","article-title":"Hepatocellular carcinoma and the Fontan circulation: clinical presentation and outcomes","volume":"322","author":"Possner","year":"2021","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100249_bib86","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2019.10.027","article-title":"Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: the VALDIG Fonliver prospective cohort","volume":"72","author":"T\u00e9llez","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2021.100249_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071805","article-title":"Risk of liver cirrhosis and hepatocellular carcinoma after fontan operation: a need for surveillance","volume":"12","author":"Yoon","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.jhepr.2021.100249_bib88","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00261-017-1181-9","article-title":"Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma","volume":"42","author":"Wells","year":"2017","journal-title":"Abdom Radiol N Y"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100249_bib89","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jhep.2018.02.018","article-title":"Positron emission tomography\/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma","volume":"69","author":"Chalaye","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"18","key":"10.1016\/j.jhepr.2021.100249_bib90","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMc1214222","article-title":"Hepatocellular carcinoma after the fontan procedure","volume":"368","author":"Asrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100249_bib91","first-page":"E55","article-title":"Surgical management of hepatocellular carcinoma after Fontan procedure","volume":"6","author":"Kwon","year":"2015","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.jhepr.2021.100249_bib92","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijscr.2019.05.029","article-title":"Laparoscopic liver resection for hepatocellular carcinoma in Fontan-associated chronic liver disease. The first case report","volume":"59","author":"Angelico","year":"2019","journal-title":"Int J Surg Case Rep"},{"issue":"12","key":"10.1016\/j.jhepr.2021.100249_bib93","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.radcr.2020.09.056","article-title":"Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient","volume":"15","author":"Orlacchio","year":"2020","journal-title":"Radiol Case Rep"},{"key":"10.1016\/j.jhepr.2021.100249_bib94","article-title":"Hepatocellular carcinoma after fontan surgery: a systematic review","author":"Rodr\u00edguez de Santiago","year":"2020","journal-title":"Hepatol Res Off J Jpn Soc Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100249_bib95","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Electronic address: easloffice@easloffice.eu, European association for the study of the liver. EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:26:53Z","timestamp":1762900013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555921000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2589555921000252"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100249","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100249"}}